Kuhr, T; Apfelbeck, U; Linkesch, W; Mistrik, M; Tothova, E; Koza, V; Lutz, D; Vorlieek, J; Cernelc, P; Bernhart, M; Lin, W; Hausmaninger, H; Greil, R; Gastl, G; Michlmayr, G; Thaler, J.
Treatment of newly-diagnosed CML patients with interferon alpha and continuous versus intermittent cytarabin-ocfosfat (YNK01): A randomized Central European Leukemia Study.
BLOOD 2003 102: 311B-311B.
Web of Science